In the News: November 2016

Many people with rheumatoid arthritis take biologic drugs, which differ from traditional drugs in that they are produced by living cells. This makes it difficult to produce cheaper generic versions. Biosimilar drugs, which are approximate copies that have the same therapeutic effect, have been created to replace traditional generic drugs. In a study published in August 2016, researchers analyzed results of 19 studies of five biologic drugs and their biosimilar counterparts.